Expression and Purification of Active Monomeric MMP7

Kazuhiro Yamamoto1, Moe Isohata2, Shouichi Higashi3

  • 1Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.

Insights

Researchers developed a new method to produce active Matrix Metalloproteinase 7 (MMP7). Adding calcium chloride during refolding significantly boosted the yield of pure, active MMP7 for therapeutic research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Chemistry

Background:

  • Matrix Metalloproteinase 7 (MMP7) is the smallest MMP, involved in various physiological and pathological processes.
  • Recombinant MMP7 production is crucial for functional studies and therapeutic inhibitor development.
  • Existing recombinant MMP7 expression methods face challenges with low yields and purity.

Purpose of the Study:

  • To establish an effective method for expressing and purifying an active form of MMP7.
  • To improve the yield and purity of active, monomeric MMP7 for research applications.

Main Methods:

  • Recombinant expression of MMP7 in E. coli.
  • Optimization of the refolding process using high concentrations of CaCl2.
  • Purification of active monomeric MMP7.

Main Results:

  • A novel refolding strategy using high CaCl2 concentration was identified.
  • This method effectively prevented non-specific binding and aggregation of MMP7.
  • Significantly improved yields of active, monomeric MMP7 were achieved.

Conclusions:

  • The described method provides an efficient way to obtain active MMP7.
  • This advancement facilitates further research into MMP7's roles and the development of MMP7-targeted therapeutics.